West Michigan Advisors LLC Buys New Shares in Axon Enterprise, Inc $AXON

West Michigan Advisors LLC bought a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 265 shares of the biotechnology company’s stock, valued at approximately $219,000.

Other large investors have also made changes to their positions in the company. TCTC Holdings LLC lifted its position in shares of Axon Enterprise by 75.0% in the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after acquiring an additional 24 shares in the last quarter. Bartlett & CO. Wealth Management LLC boosted its stake in Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock valued at $31,000 after buying an additional 33 shares during the last quarter. Banque Transatlantique SA purchased a new position in Axon Enterprise during the 1st quarter valued at approximately $31,000. Catalyst Capital Advisors LLC purchased a new position in Axon Enterprise during the 1st quarter valued at approximately $32,000. Finally, Flaharty Asset Management LLC purchased a new position in Axon Enterprise during the 1st quarter valued at approximately $33,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

AXON has been the subject of several research analyst reports. Zacks Research cut Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 2nd. Morgan Stanley set a $885.00 price objective on Axon Enterprise and gave the stock an “overweight” rating in a research note on Friday, July 11th. Bank of America boosted their price objective on Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research note on Wednesday, August 6th. Needham & Company LLC reissued a “buy” rating and set a $870.00 price objective on shares of Axon Enterprise in a research note on Wednesday, September 24th. Finally, JPMorgan Chase & Co. increased their price objective on Axon Enterprise from $730.00 to $850.00 and gave the stock an “overweight” rating in a research note on Thursday, July 17th. Fourteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $841.64.

Axon Enterprise Stock Up 2.7%

Axon Enterprise stock opened at $735.95 on Friday. The business has a fifty day moving average of $733.17 and a two-hundred day moving average of $723.75. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. The firm has a market cap of $57.78 billion, a P/E ratio of 181.72, a P/E/G ratio of 27.82 and a beta of 1.41. Axon Enterprise, Inc has a twelve month low of $422.38 and a twelve month high of $885.91.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating the consensus estimate of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm had revenue of $668.54 million during the quarter, compared to analyst estimates of $641.77 million. During the same quarter in the prior year, the business posted $1.20 EPS. The business’s revenue for the quarter was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. On average, analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Insider Activity

In related news, CAO Jennifer H. Mak sold 77 shares of the firm’s stock in a transaction on Monday, September 15th. The stock was sold at an average price of $760.00, for a total value of $58,520.00. Following the completion of the transaction, the chief accounting officer owned 15,003 shares in the company, valued at $11,402,280. This trade represents a 0.51% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $713.74, for a total value of $7,137,400.00. Following the completion of the transaction, the chief executive officer owned 3,033,982 shares of the company’s stock, valued at $2,165,474,312.68. This trade represents a 0.33% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 59,932 shares of company stock worth $45,115,616. Company insiders own 4.40% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.